Pilot study: Evaluation of potential drug–drug interactions in hospitalized pediatric patients

Purpose: Evaluate the type and severity of potential drug-drug interactions and identify risk factors involved, in pediatric patients admitted in a hospital setting. Methods: Transversal retrospective analytical study was carried out with hospitalized pediatric patients from a Hospital in the West o...

Full description

Saved in:
Bibliographic Details
Main Authors: Fabiola Medina-Barajas, Estefanía Vázquez-Méndez, Edsaúl Emilio Pérez-Guerrero, Virginia Aleyda Sánchez-López, Iván I. Hernández-Cañaveral, Real-Ornelas Gabriel A, Selene G. Huerta-Olvera
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Pediatrics and Neonatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1875957219305467
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850259936185942016
author Fabiola Medina-Barajas
Estefanía Vázquez-Méndez
Edsaúl Emilio Pérez-Guerrero
Virginia Aleyda Sánchez-López
Iván I. Hernández-Cañaveral
Real-Ornelas Gabriel A
Selene G. Huerta-Olvera
author_facet Fabiola Medina-Barajas
Estefanía Vázquez-Méndez
Edsaúl Emilio Pérez-Guerrero
Virginia Aleyda Sánchez-López
Iván I. Hernández-Cañaveral
Real-Ornelas Gabriel A
Selene G. Huerta-Olvera
author_sort Fabiola Medina-Barajas
collection DOAJ
description Purpose: Evaluate the type and severity of potential drug-drug interactions and identify risk factors involved, in pediatric patients admitted in a hospital setting. Methods: Transversal retrospective analytical study was carried out with hospitalized pediatric patients from a Hospital in the West of Mexico, second and third level. The patients included were ≤18 years old hospitalized in the children wards; those admitted at the emergency room, neonatal intermediate and intensive therapy units were not included. Medical prescriptions were reviewed taking into consideration anthropometric characteristics, diagnosis and number of drugs prescribed to identify potential drug–drug interactions using Micromedex 2.0 database. Results: 88 patients were included, an average of 4.6 ± 2.8 of drugs were prescribed per patient. 37 subjects (42%) presented some degree of potential drug-drug interactions of which 25.5% were major and 27.7% moderate according to the software. Identified risk factors were: age ≥ 4 years (OR 1.917; 95% CI 1.081-3.399), BSA ≥ 0.8m2(OR 1.825; 95% CI 1.021–3.263), height ≥ 1 m (OR 2.556;95% CI 1.322 - 4.941), and number of prescribed medications ≥ 4 (OR 2.106;95% CI 1.248 - 3.556). Conclusion: Some of the interactions found were for the benefit of the patient, but others were considered undesirable because they altered the pharmacokinetics of some of the medications administered. Detecting in time the harmful interactions for a patient may favor the patient's safety.
format Article
id doaj-art-efe5aa55303448dba225fb17bcbe8558
institution OA Journals
issn 1875-9572
language English
publishDate 2020-06-01
publisher Elsevier
record_format Article
series Pediatrics and Neonatology
spelling doaj-art-efe5aa55303448dba225fb17bcbe85582025-08-20T01:55:45ZengElsevierPediatrics and Neonatology1875-95722020-06-0161327928910.1016/j.pedneo.2019.11.006Pilot study: Evaluation of potential drug–drug interactions in hospitalized pediatric patientsFabiola Medina-Barajas0Estefanía Vázquez-Méndez1Edsaúl Emilio Pérez-Guerrero2Virginia Aleyda Sánchez-López3Iván I. Hernández-Cañaveral4Real-Ornelas Gabriel A5Selene G. Huerta-Olvera6Pharmacy Service, Nuevo Hospital Civil de Guadalajara “Dr. Juan I. Menchaca”, 750 Salvador Quevedo y Zubieta St., 44340, Guadalajara, MexicoMedical and Pharmaceutical Biotechnology Department, Centro de Asistencia en Tecnología y Diseño del Estado de Jalisco, 800 Normalistas Av., 44270, Guadalajara, MexicoMolecular Biology and Genomics Department, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 950 Sierra Mojada St., 44340, Guadalajara, MexicoPharmacovigilance Department, Laboratorios PiSA, 1840 España Ave., 44190, Guadalajara, MexicoMicrobiology Department, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 950 Sierra Mojada St., 44340, Guadalajara, MexicoCentro integral de Medicina Ambiental y Toxicología CIMATOX S.A.S, de C.V. María Reyes 2, Guadalajara, MexicoMedical and Life Sciences Department, Centro Universitario de la Ciénega, Universidad de Guadalajara, 1115 Universidad Av., 47820, Ocotlán, Mexico; Corresponding author.Purpose: Evaluate the type and severity of potential drug-drug interactions and identify risk factors involved, in pediatric patients admitted in a hospital setting. Methods: Transversal retrospective analytical study was carried out with hospitalized pediatric patients from a Hospital in the West of Mexico, second and third level. The patients included were ≤18 years old hospitalized in the children wards; those admitted at the emergency room, neonatal intermediate and intensive therapy units were not included. Medical prescriptions were reviewed taking into consideration anthropometric characteristics, diagnosis and number of drugs prescribed to identify potential drug–drug interactions using Micromedex 2.0 database. Results: 88 patients were included, an average of 4.6 ± 2.8 of drugs were prescribed per patient. 37 subjects (42%) presented some degree of potential drug-drug interactions of which 25.5% were major and 27.7% moderate according to the software. Identified risk factors were: age ≥ 4 years (OR 1.917; 95% CI 1.081-3.399), BSA ≥ 0.8m2(OR 1.825; 95% CI 1.021–3.263), height ≥ 1 m (OR 2.556;95% CI 1.322 - 4.941), and number of prescribed medications ≥ 4 (OR 2.106;95% CI 1.248 - 3.556). Conclusion: Some of the interactions found were for the benefit of the patient, but others were considered undesirable because they altered the pharmacokinetics of some of the medications administered. Detecting in time the harmful interactions for a patient may favor the patient's safety.http://www.sciencedirect.com/science/article/pii/S1875957219305467drug-drug interactionsmedication errorspediatric patientspotential drug-drug interactions
spellingShingle Fabiola Medina-Barajas
Estefanía Vázquez-Méndez
Edsaúl Emilio Pérez-Guerrero
Virginia Aleyda Sánchez-López
Iván I. Hernández-Cañaveral
Real-Ornelas Gabriel A
Selene G. Huerta-Olvera
Pilot study: Evaluation of potential drug–drug interactions in hospitalized pediatric patients
Pediatrics and Neonatology
drug-drug interactions
medication errors
pediatric patients
potential drug-drug interactions
title Pilot study: Evaluation of potential drug–drug interactions in hospitalized pediatric patients
title_full Pilot study: Evaluation of potential drug–drug interactions in hospitalized pediatric patients
title_fullStr Pilot study: Evaluation of potential drug–drug interactions in hospitalized pediatric patients
title_full_unstemmed Pilot study: Evaluation of potential drug–drug interactions in hospitalized pediatric patients
title_short Pilot study: Evaluation of potential drug–drug interactions in hospitalized pediatric patients
title_sort pilot study evaluation of potential drug drug interactions in hospitalized pediatric patients
topic drug-drug interactions
medication errors
pediatric patients
potential drug-drug interactions
url http://www.sciencedirect.com/science/article/pii/S1875957219305467
work_keys_str_mv AT fabiolamedinabarajas pilotstudyevaluationofpotentialdrugdruginteractionsinhospitalizedpediatricpatients
AT estefaniavazquezmendez pilotstudyevaluationofpotentialdrugdruginteractionsinhospitalizedpediatricpatients
AT edsaulemilioperezguerrero pilotstudyevaluationofpotentialdrugdruginteractionsinhospitalizedpediatricpatients
AT virginiaaleydasanchezlopez pilotstudyevaluationofpotentialdrugdruginteractionsinhospitalizedpediatricpatients
AT ivanihernandezcanaveral pilotstudyevaluationofpotentialdrugdruginteractionsinhospitalizedpediatricpatients
AT realornelasgabriela pilotstudyevaluationofpotentialdrugdruginteractionsinhospitalizedpediatricpatients
AT seleneghuertaolvera pilotstudyevaluationofpotentialdrugdruginteractionsinhospitalizedpediatricpatients